top of page
Medex EU Authorised Representative logo

EU Authorized Representative for ECG Device Manufacturers: Rule 10, Rule 11 Software and the Mandate

An electrocardiograph is an active device for diagnosis and monitoring under Regulation (EU) 2017/745. Rule 10 of Annex VIII places a diagnostic ECG in class IIa and a monitor whose alarms protect a patient in immediate danger in class IIb, while the electrodes are class I under Rule 1 and stand-alone analysis software is classified under Rule 11. A manufacturer established outside the Union must designate a sole authorized representative under Article 11 for all of them, and one mandate covers the EU and Türkiye.

An electrocardiograph is an active device for diagnosis and monitoring

An ECG recorder amplifies and converts the electrical signal of the heart, so it is an active device under Article 2(4) and, more specifically:

"‘Active device intended for diagnosis and monitoring’ means any active device used, whether alone or in combination with other devices, to supply information for detecting, diagnosing, monitoring or treating physiological conditions, states of health, illnesses or congenital deformities." (MDR Annex VIII, Section 2.5)

Rule 10 therefore classifies it. Electrodes, software and any therapy function are classified separately.

Rule 10: class IIa for diagnosis, class IIb where variations endanger the patient

"Active devices intended for diagnosis and monitoring are classified as class IIa:" (MDR Annex VIII, Rule 10)

  • "if they are intended to allow direct diagnosis or monitoring of vital physiological processes, unless they are specifically intended for monitoring of vital physiological parameters and the nature of variations of those parameters is such that it could result in immediate danger to the patient, for instance variations in cardiac performance, respiration, activity of the central nervous system, or they are intended for diagnosis in clinical situations where the patient is in immediate danger, in which cases they are classified as class IIb."

MDCG 2021-24 lists electrocardiographs as a class IIa example under the third indent, and under the class IIb branch it lists multi-parameter patient monitors with alarms, for example in intensive care, and apnoea monitors including those in home care. The line is the intended purpose: a resting ECG recording a trace for interpretation allows direct diagnosis and is class IIa; a monitor whose alarms are relied on to catch arrhythmia in a patient in immediate danger is class IIb. Section 3.7 explains direct diagnosis:

"A device is considered to allow direct diagnosis when it provides the diagnosis of the disease or condition in question by itself or when it provides decisive information for the diagnosis." (MDR Annex VIII, Section 3.7)

Four product types follow:

  • Resting electrocardiographs, 3-, 6- and 12-lead, with or without interpretation printout: class IIa, because they allow direct diagnosis of cardiac conditions.
  • Holter and event recorders analysed after the recording: class IIa where the device only stores the trace for later review; class IIb where the manufacturer intends it to alarm in real time on variations that could put the patient in immediate danger.
  • Bedside and telemetry patient monitors with arrhythmia alarms used in intensive or emergency care: class IIb.

Where a product carries both intended purposes, Section 3.5 applies and the stricter sub-rule governs.

Electrodes, cables and ECG software

"All non-invasive devices are classified as class I, unless one of the rules set out hereinafter applies." (MDR Annex VIII, Rule 1)

MDCG 2021-24 lists non-invasive electrodes for EEG or ECG as a class I example under Rule 1. Patient cables transmit the signal without significant change and are not active devices under the second sentence of Article 2(4). Both are classified separately under Section 3.2, and a non-sterile electrode needs no notified body. Firmware and analysis software that drive the electrocardiograph are classified with it under Section 3.3. Stand-alone software that interprets a trace, or an app using a wearable sensor, is classified in its own right under Rule 11:

"Software intended to provide information which is used to take decisions with diagnosis or therapeutic purposes is classified as class IIa, except if such decisions have an impact that may cause:" (MDR Annex VIII, Rule 11)

  • "death or an irreversible deterioration of a person's state of health, in which case it is in class III; or"
  • "a serious deterioration of a person's state of health or a surgical intervention, in which case it is classified as class IIb."

MDCG 2021-24 gives a mobile app intended to analyse a user's heartbeat, detect abnormalities and inform a physician as a class IIb example, and notes that software is classified in the same way regardless of where it runs. Software that only records, stores or displays the trace is generally not a device under MDCG 2019-11; the medical device software page covers qualification and Rule 11 in detail.

ECG with a therapy function, and devices that read implants

An automated external defibrillator analyses the ECG and decides whether to shock; Rule 22 names automated external defibrillators as class III. They belong to the defibrillators page. A programmer or monitor that reads an implantable cardiac device is class III under the fourth paragraph of Rule 9.

Classification table for an ECG range

Product variantClassRuleNotified body
Resting 12-lead electrocardiograph, with or without interpretationIIaRule 10, third indentYes
Holter or event recorder storing the trace for later reviewIIaRule 10, third indentYes
Recorder or wearable alarming in real time on life-threatening arrhythmiaIIbRule 10, third indent, immediate danger branchYes
Bedside or telemetry patient monitor with arrhythmia alarmsIIbRule 10, third indent, immediate danger branchYes
ECG electrodes, non-sterile; patient cableIRule 1; Article 2(4) second sentenceNo
Stand-alone ECG interpretation software or heartbeat analysis appIIa, IIb or IIIRule 11Yes
Automated external defibrillatorIIIRule 22Yes
Programmer or monitor for an implantable pacemaker or ICDIIIRule 9, fourth paragraphYes

Conformity assessment: Article 52(6) and 52(4)

"Manufacturers of class IIa devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Chapters I and III of Annex IX, and including an assessment of the technical documentation as specified in Section 4 of that Annex of at least one representative device for each category of devices." (MDR Article 52(6))

Class IIb monitors follow Article 52(4). Electrical safety, electromagnetic compatibility and software life cycle documentation sit in the technical documentation the notified body reviews. Class I electrodes follow Article 52(7) with no notified body unless supplied sterile.

What the authorized representative mandate covers for ECG devices

The appointment turns on where the manufacturer is established, not on the class of the device:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Article 11(1))

Article 11(3) fixes the minimum tasks:

"The mandate shall require, and the manufacturer shall enable, the authorised representative to perform at least the following tasks in relation to the devices that it covers:" (MDR Article 11(3))

  • "verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
  • "in response to a request from a competent authority, provide that competent authority with all the information and documentation necessary to demonstrate the conformity of a device, in an official Union language determined by the Member State concerned;"

For a connected ECG product the representative also checks that the software version placed on the market is the one covered by the certificate and reflected in the EUDAMED device record.

One mandate for the European Union and Türkiye

Medex Kurumsal Danışmanlık acts as EU authorized representative under EUDAMED SRN TR-AR-000057550, with offices in Ankara and İstanbul. A manufacturer of ECG devices established outside the EU and Türkiye does not need two representatives:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey." (European Commission, Notice to Stakeholders, EU-Turkey Customs Union Agreement in the field of medical devices, March 2022, section I.2)

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey." (MDCG 2022-16, footnote 1)

Our mandate covers the EU Member States and Türkiye; we are not a Swiss representative or UK Responsible Person, not a notified body, and we do not find importers or distributors. The published bands on our pricing page are €800 to 1,000 per year for class I, €1,000 to 1,300 per year for class IIa, €1,200 to 1,600 per year for class IIb, with a €0 setup fee and rates fixed for three years from signature. Registration of the same ECG devices in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, is a separate service: ÜTS registration of ECG devices in Türkiye (Turkish).

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related device categories and country pages

Related active device groups: medical device software, continuous glucose monitors and blood pressure monitors and thermometers. All groups are listed on the medical device categories page, and the manufacturer country pages start from the EU authorized representative by country list.

Frequently asked questions

Which class is a 12-lead resting ECG?

Class IIa. It is an active device intended to allow direct diagnosis of cardiac conditions, which is the third indent of Rule 10. MDCG 2021-24 lists electrocardiographs as a class IIa example.

When does an ECG product become class IIb?

Where it is specifically intended for monitoring of vital physiological parameters whose variations could result in immediate danger to the patient, for instance variations in cardiac performance. MDCG 2021-24 lists patient monitors with alarms and apnoea monitors as class IIb examples.

Are ECG electrodes classified with the recorder?

No. Electrodes are classified in their own right under Annex VIII, Section 3.2. They contact intact skin and are not active, so Rule 1 places them in class I, and MDCG 2021-24 lists non-invasive electrodes for EEG or ECG there. Non-sterile electrodes need no notified body.

Which class is a smartphone ECG app?

If the app analyses the heartbeat and informs a physician of abnormalities, MDCG 2021-24 gives it as a class IIb example under Rule 11. An app that only displays or stores the trace is generally not a device. Software that drives the recorder itself takes the class of the recorder under Section 3.3.

Does one mandate cover the European Union and Türkiye?

Yes. Under the EU-Türkiye Customs Union a manufacturer established outside both territories needs only one authorized representative, established in the EU or in Türkiye. Medex is established in Türkiye under EUDAMED SRN TR-AR-000057550.

Sources and further reading

Regulation (EU) 2017/745 on medical devices (MDR), Articles 2, 10, 11, 18, 32, 52 and 54, Annex VIII - eur-lex.europa.eu

MDCG 2021-24, Guidance on classification of medical devices (October 2021) - health.ec.europa.eu

MDCG 2022-16, Guidance on authorised representatives (Regulation (EU) 2017/745 and Regulation (EU) 2017/746) - health.ec.europa.eu

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022) - health.ec.europa.eu

Get a fixed-price EU REP quote for your ECG device range (reply within 1 business day).

Request a proposal  ·  View pricing  ·  Our EU REP service

bottom of page